Literature DB >> 7950154

Extracoronary atherosclerosis and genetic variants of apolipoprotein AI-CIII cluster in myocardial infarction survivors from southern Italy.

F De Lorenzo1, A Monticelli, S Cocozza, B De Simone, P Rubba.   

Abstract

The relationships between some genetic markers, as evaluated by DNA analysis, and ultrasound evidence of extracoronary athero-sclerosis, as detected by ultrasound methods, were evaluated in 39 myocardial infarction survivors of middle age and in 40 healthy controls of comparable age. Coronary heart disease (CHD) patients showed higher levels of triglycerides (P = 0.01) and greater number of exsmokers (P = 0.004). Carotid stenoses (> 15%) were detected in ten CHD patients and in two controls; iliac stenoses (> 15%) or abnormal ankle/arm ratio (< 0.97) were found in ten CHD patients and in one control; the scores of vascular disease severity in the myocardial infarction survivors were higher (Mann-Whitney test) than in controls (P < 0.01). Molecular genetic analysis of SstI restriction fragment length polymorphism (RFLP) of the apolipoprotein (apo) AI-CIII cluster and of the apo B gene demonstrated a higher frequency of the S2 allele (SstI RFLP) in coronary patients than in controls (P = 0.04) and no significant differences in the frequencies of XbaI RFLP of the apo B gene between patients and controls. The relative risk of myocardial infarction associated with an abnormal vascular score (> 8) or with the presence of the rare allele S2 (SstI apo AI-CIII polymorphism) was estimated by odds ratios. The lower 95% limits of odds ratios were above 1 (indicating significant increase in the relative risk of myocardial infarction) both in the case of vascular score and that of SstI RFLP. These associations were independent of one another and of triglyceride levels. SstI RFLP association with CHD disappeared after adjustment for smoking habits.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7950154     DOI: 10.1007/bf00180517

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  36 in total

1.  Mortality over a period of 10 years in patients with peripheral arterial disease.

Authors:  M H Criqui; R D Langer; A Fronek; H S Feigelson; M R Klauber; T J McCann; D Browner
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

2.  DNA polymorphisms of apolipoprotein A-I/C-III and insulin genes in familial hypertriglyceridemia and coronary heart disease.

Authors:  K Aalto-Setälä; K Kontula; T Sane; M Nieminen; E Nikkilä
Journal:  Atherosclerosis       Date:  1987-07       Impact factor: 5.162

3.  Genetic polymorphisms of apolipoprotein C-III and insulin in survivors of myocardial infarction.

Authors:  G A Ferns; J Stocks; C Ritchie; D J Galton
Journal:  Lancet       Date:  1985-08-10       Impact factor: 79.321

4.  Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease.

Authors:  J M Ordovas; F Civeira; J Genest; S Craig; A H Robbins; T Meade; M Pocovi; P M Frossard; U Masharani; P W Wilson
Journal:  Atherosclerosis       Date:  1991-03       Impact factor: 5.162

5.  Noninvasive evaluation of arteriosclerosis. Comparison of methods.

Authors:  D E Strandness
Journal:  Arteriosclerosis       Date:  1983 Mar-Apr

Review 6.  A survey of 246 suggested coronary risk factors.

Authors:  P N Hopkins; R R Williams
Journal:  Atherosclerosis       Date:  1981 Aug-Sep       Impact factor: 5.162

7.  Isolation and characterization of cDNA clones corresponding to two different human apoC-III alleles.

Authors:  S K Karathanasis; V I Zannis; J L Breslow
Journal:  J Lipid Res       Date:  1985-04       Impact factor: 5.922

8.  Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study.

Authors:  T E Craven; J E Ryu; M A Espeland; F R Kahl; W M McKinney; J F Toole; M R McMahan; C J Thompson; G Heiss; J R Crouse
Journal:  Circulation       Date:  1990-10       Impact factor: 29.690

9.  Lack of correlation between the apolipoprotein B XbaI polymorphism and blood lipid levels in a Swedish population.

Authors:  C Darnfors; O Wiklund; J Nilsson; B Gerard; P Carlsson; S Johansson; G Bondjers; G Bjursell
Journal:  Atherosclerosis       Date:  1989-02       Impact factor: 5.162

10.  DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary artery disease.

Authors:  J J Genest; J M Ordovas; J R McNamara; A M Robbins; T Meade; S D Cohn; D N Salem; P W Wilson; U Masharani; P M Frossard
Journal:  Atherosclerosis       Date:  1990-05       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.